Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is estimated to afflict approximately 1 billion
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …
individuals worldwide. In a subset of NAFLD patients, who have the progressive form of …
Liver cirrhosis
Cirrhosis is widely prevalent worldwide and can be a consequence of different causes, such
as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C …
as obesity, non-alcoholic fatty liver disease, high alcohol consumption, hepatitis B or C …
EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis–2021 update
Non-invasive tests are increasingly being used to improve the diagnosis and
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …
prognostication of chronic liver diseases across aetiologies. Herein, we provide the latest …
[HTML][HTML] Non-alcoholic fatty liver disease: A patient guideline
This patient guideline is intended for all patients at risk of or living with non-alcoholic fatty
liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and …
liver disease (NAFLD). NAFLD is the most frequent chronic liver disease worldwide and …
EASL recommendations on treatment of hepatitis C: final update of the series☆
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
AASLD Practice Guideline on imaging-based noninvasive liver disease assessment of hepatic fibrosis and steatosis
Chronic liver disease (CLD) is associated with approximately two million annual deaths
worldwide and is an enormous health burden.[1, 2] The majority of liver-related outcomes …
worldwide and is an enormous health burden.[1, 2] The majority of liver-related outcomes …
[HTML][HTML] Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations
Abstract The World Federation for Ultrasound in Medicine and Biology has produced these
guidelines for the use of elastography techniques in liver diseases. For each available …
guidelines for the use of elastography techniques in liver diseases. For each available …
Deep learning Radiomics of shear wave elastography significantly improved diagnostic performance for assessing liver fibrosis in chronic hepatitis B: a prospective …
Objective We aimed to evaluate the performance of the newly developed deep learning
Radiomics of elastography (DLRE) for assessing liver fibrosis stages. DLRE adopts the …
Radiomics of elastography (DLRE) for assessing liver fibrosis stages. DLRE adopts the …
EASL recommendations on treatment of hepatitis C 2018
Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
approximately 71 million chronically infected individuals worldwide. Clinical care for patients …
[HTML][HTML] Imaging biomarkers of NAFLD, NASH, and fibrosis
Background Non-alcoholic fatty liver disease (NAFLD) is a clinicopathologic entity that
requires a liver biopsy assessment to diagnose the progressive form of NAFLD called non …
requires a liver biopsy assessment to diagnose the progressive form of NAFLD called non …